High-sensitivity C-reactive protein measurements in patients with non-arteritic anterior ischaemic optic neuropathy: A clue to the presence of a microinflammatory response

Acta Ophthalmologica

Volumn 87, Issue 2, 2009, Pages 216-221

  Kesler, Anat ^a,b   Irge, Dana ^b   Rogowski, Ori ^b   Bornstein, Natan ^b   Berliner, Shlomo ^b   Shapira, Itzhak ^b   Shani, Shenhar Tsarfaty ^b   Ben Assayag, Einor ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

C reactive protein; Microinflammation; Non arteritic anterior ischaemic optic neuropathy; Sedimentation rate

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEVOTHYROXINE SODIUM; NITRATE; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; EYE INFLAMMATION; FEMALE; GROUPS BY AGE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; LEUKOCYTE COUNT; MALE; MOUTH TEMPERATURE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT; THROMBOSIS;

AGED; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; OSMOLAR CONCENTRATION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 61449116816     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01199.x     Document Type: Article

References (33)

1. Beri M, Klugman MR, Kohler JA et al. (1987 Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology 94 : 1020 1028.
2. Berliner S, Rogowski O, Aharonov S et al. (2005a Erythrocyte adhesiveness/aggregation. A novel biomarker for the detection of low grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J 149 : 260 267.
3. Berliner S, Shapira I, Toker S et al. (2005b Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol Dis 34 : 135 140.
4. Biasucci LM (2004 CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110 : 560 567.
5. Clauss A (1957 Coagulants physiological rapid method for the determination of fibrinogen. Acta Haematol 17 : 237 246.
6. Costello F, Zimmerman MB, Podhajsky PA et al. (2004 Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol 14 : 245 257.
7. Danesh J, Collins R, Peto R et al. (2000 Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 21 : 515 520.
8. Dutton JJ Burde RM (1983 Anterior ischemic optic neuropathy of the young. J Clin Neuroophthalmol 3 : 137 146.
9. Ehrenstein MR, Jury EC Mauri C (2005 Statins for atherosclerosis - as good as it gets? N Engl J Med 352 : 73 75.
10. Feldman M, Jialal I, Devaraj S et al. (2001 Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 37 : 2036 2041.
11. Feng D, Tracy RP, Lipinska I et al. (2000 Effect of short-term aspirin use on C-reactive protein. J Thromb Thrombolysis 9 : 37 41.
12. Gabay C Kushner I (1999 Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 11 : 448 454.
13. García-Lorda P, Bulló M, Balanzà R et al. (2006 C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. Int J Obes (Lond) 30 : 468 474.
14. Hayreh SS (1981 Anterior ischemic optic neuropathy. Arch Neurol 38 : 675 678.
15. International Committee for Standardization in Hematology (1965 Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2 : 235 254.
16. Janáky M, Fülöp Z, Pálffy A et al. (2005 Non-arteritic ischaemic optic neuropathy (NAION) in patients under 50 years of age. Acta Ophthalmol Scand 83 : 499 503.
17. Jialal I, Devaraj S Venugopal SK (2004 C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44 : 6 11.
18. Johnson LN Arnold AC (1994 Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol 14 : 38 44.
19. Labarrere CA Zaloga GP (2004 C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 117 : 499 507.
20. Libby P, Ridker PM Maseri A (2002 Inflammation and atherosclerosis. Circulation 105 : 1135 1143.
21. Madjid M, Awan I, Willerson JT et al. (2004 Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44 : 1945 1956.
22. Maresca G, Di Blasio A, Marchioli R et al. (1999 Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 19 : 1368 1377.
23. Ridker PM (2002 On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 105 : 2 4.
24. Ridker PM (2003 Cardiology patient page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 108 : 81 85.
25. Rifai N, Tracy RP Ridker PM (1999 Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45 : 2136 2141.
26. Rogowski O, Shapira I, Zimran A et al. (2005a Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells Mol Dis 34 : 26 29.
27. Rogowski O, Toker S, Shapira I et al. (2005b Values of high sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol 95 : 152 155.
28. Rogowski O, Shapira I, Ben Assayag E et al. (2006 Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events. Blood Coagul Fibrinolysis 17 : 19 22.
29. Rogowski O, Vered Y, Shapira I et al. (2005 Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta 358 : 151 158.
30. Takeda T, Hoshida S, Nishino M et al. (2003 Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 169 : 155 158.
31. Veldhuijzen van Zanten JJ, Ring C, Carroll D et al. (2005 Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis. Ann Rheum Dis 64 : 1299 1304.
32. Viles-Gonzalez JF, Fuster V Badimon JJ (2004 Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 25 : 1197 1207.
33. Walston J, McBurnie MA, Newman A et al. (2002 Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162 : 2333 2341.